Quarterly report pursuant to Section 13 or 15(d)

DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)

v3.10.0.1
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)
6 Months Ended
Jun. 30, 2018
Celtic Biotech Iowa, Inc. [Member]  
Subsidiary Celtic Biotech Iowa, Inc.
Percentage of Non-controlling Interest 5.00%
Owner of Non-controlling Interest Various
Caretta Therapeutics, LLC [Member]  
Subsidiary Caretta Therapeutics, LLC
Percentage of Non-controlling Interest 35.00%
Owner of Non-controlling Interest K4 Enterprises
SMA Therapeutics, LLC [Member]  
Subsidiary SMA Therapeutics, LLC
Percentage of Non-controlling Interest 20.00%
Owner of Non-controlling Interest K4 Enterprises
Zika Therapeutics, LLC [Member]  
Subsidiary Zika Therapeutics, LLC
Percentage of Non-controlling Interest 20.00%
Owner of Non-controlling Interest K4 Enterprises